Wedbush Reiterates Outperform on Astria Therapeutics, Maintains $17 Price Target

Astria Therapeutics Inc Ordinary Shares 0.00%

Astria Therapeutics Inc Ordinary Shares

ATXS

9.02

0.00%

Wedbush analyst Laura Chico reiterates Astria Therapeutics (NASDAQ: ATXS) with a Outperform and maintains $17 price target.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via